UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 101

Sortiert nach

Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions

Cancers, 2021-11, Vol.13 (22), p.5827

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation

Bone marrow transplantation (Basingstoke), 2021-03, Vol.56 (3), p.741-744

2021

Link zum Volltext

Verfügbarkeit prüfen

Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis

Annals of hematology, 2021-04, Vol.100 (4), p.969-978

2021

Link zum Volltext

Verfügbarkeit prüfen

Absolute lymphocyte count on the first day of thymoglobulin predicts relapse-free survival in matched unrelated peripheral blood stem cell transplantation

Leukemia & lymphoma, 2020-11, Vol.61 (13), p.3137-3145

2020

Link zum Volltext

Verfügbarkeit prüfen

Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation

American journal of hematology, 2016-09, Vol.91 (9), p.E341-E347

2016

Link zum Volltext

Verfügbarkeit prüfen

P1144: PHASE 2 WAVELINE‐004 STUDY: ZILOVERTAMAB VEDOTIN (MK‐2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)

HemaSphere, 2023-08, Vol.7 (S3), p.e03345ef-n/a

2023

Link zum Volltext

Verfügbarkeit prüfen

Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma

The American journal of the medical sciences, 2015-09, Vol.350 (3), p.241-242

2015

Link zum Volltext

Verfügbarkeit prüfen

Radium-223 in Heavily Pretreated Metastatic Castrate Resistant Prostate Cancer

Clinical genitourinary cancer, 2016-10, Vol.14 (5), p.373-380.e2

2016

Link zum Volltext

Verfügbarkeit prüfen

Malignant Cause of Abdominal Pain in Leukemia: Spontaneous Splenic Rupture

The American journal of the medical sciences, 2015-02, Vol.349 (2), p.189-190

2015

Link zum Volltext

Verfügbarkeit prüfen

Tafasitamab (TAFA) Plus Lenalidomide (LEN) Prior to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Case Series of 8 Patients

Blood, 2022-11, Vol.140 (Supplement 1), p.12089-12091

2022

Link zum Volltext

Verfügbarkeit prüfen

Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis

Bone marrow transplantation (Basingstoke), 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

A Phase II Study Evaluating Safety and Efficacy of Polatuzumab Vedotin in Combination with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients with Previously Untreated Double and Triple Hit Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.3561-3561

2021

Link zum Volltext

Verfügbarkeit prüfen

HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?

Blood, 2022-11, Vol.140 (Supplement 1), p.694-695

2022

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic hematopoietic stem cell transplantation in T-cell lymphoma: a Meta-Analysis

Leukemia & lymphoma, 2022-03, Vol.63 (4), p.855-864

2022

Link zum Volltext

Verfügbarkeit prüfen

Feasibility of Outpatient CAR T Cell Therapy: Experience of a Single Institution

Blood, 2021-11, Vol.138 (Supplement 1), p.4828-4828

2021

Link zum Volltext

Verfügbarkeit prüfen

An analysis of a first-in-human study of NEXI-001 donor-derived antigen-specific CD8+ T-cell treatment of relapsed AML after allogeneic hematopoietic cell transplantation (HCT)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.7043-7043

2023

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission

Leukemia & lymphoma, 2023-07, Vol.ahead-of-print (ahead-of-print), p.1-10

2023

Link zum Volltext

Verfügbarkeit prüfen

Does Choice of Salvage Regimen Impact Stem Cell Mobilization in Hodgkin's Lymphoma?

Blood, 2022-11, Vol.140 (Supplement 1), p.7565-7566

2022

Link zum Volltext

Verfügbarkeit prüfen

Incidence, Risk Factors and Outcomes of Cardiac Toxicity in Haploidentical Peripheral Stem Cell Transplantation with High Dose Cyclophosphamide

Blood, 2020-11, Vol.136 (Supplement 1), p.35-36

2020

Link zum Volltext

Verfügbarkeit prüfen

Grade 3-4 cytokine release syndrome is associated with poor survival in haploidentical peripheral blood stem cell transplantation

Leukemia & lymphoma, 2021-07, Vol.62 (8), p.1982-1989

2021

Link zum Volltext

Verfügbarkeit prüfen

Outcome of Severe Aplastic Anemia Post Allogenic Stem Cell Transplant with Mycophenolate and Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis

Blood, 2021-11, Vol.138 (Supplement 1), p.4879-4879

2021

Link zum Volltext

Verfügbarkeit prüfen

Incidence, Risk Factors and Outcomes of Pancytopenia Following Chimeric Antigen Receptor (CAR)-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma

Blood, 2021-11, Vol.138 (Supplement 1), p.4812-4812

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 101

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(99)

Publikationsform

Sprache

Englisch
(101)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(35)
Science & Technology
(35)
Hematology
(27)
Humans
(24)
Oncology
(18)
Stem Cell Transplantation
(14)
Transplantation
(14)
Adult
(13)
Middle Aged
(13)
Retrospective Studies
(12)
Aged
(11)
Male
(11)
Stem Cells
(9)
Female
(8)
Immunology
(8)
Hematopoietic Stem Cell Transplantation
(7)
Hematopoietic Stem Cell Transplantation - Adverse Effects
(7)
Transplantation Conditioning
(7)
Transplants & Implants
(7)
Allografts
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Immunotherapy for Diffuse Large B-Cell Lymphoma: Current Landscape and Future Directions

Comparison of myeloablative and reduced intensity conditioning regimens in haploidentical peripheral blood stem cell transplantation

Comparison of myeloablative and reduced intensity conditioning unrelated donor allogeneic peripheral blood stem cell transplant outcomes for AML using thymoglobulin for GVHD prophylaxis

Absolute lymphocyte count on the first day of thymoglobulin predicts relapse-free survival in matched unrelated peripheral blood stem cell transplantation

Incidence, etiology, and outcome of pleural effusions in allogeneic hematopoietic stem cell transplantation

P1144: PHASE 2 WAVELINE‐004 STUDY: ZILOVERTAMAB VEDOTIN (MK‐2140) IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B‐CELL LYMPHOMA (DLBCL)

Pomalidomide-Induced Pulmonary Toxicity in Multiple Myeloma

Radium-223 in Heavily Pretreated Metastatic Castrate Resistant Prostate Cancer

P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma

Malignant Cause of Abdominal Pain in Leukemia: Spontaneous Splenic Rupture

Tafasitamab (TAFA) Plus Lenalidomide (LEN) Prior to Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL): Case Series of 8 Patients

Haploidentical vs. mismatched unrelated donor transplants with posttransplant cyclophosphamide-based GVHD prophylaxis

A Phase II Study Evaluating Safety and Efficacy of Polatuzumab Vedotin in Combination with Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone in Patients with Previously Untreated Double and Triple Hit Lymphoma

HLA-Haploidentical Vs Mismatched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis for AML and MDS: Is There a Winner?

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis

Allogeneic hematopoietic stem cell transplantation in T-cell lymphoma: a Meta-Analysis

Feasibility of Outpatient CAR T Cell Therapy: Experience of a Single Institution

An analysis of a first-in-human study of NEXI-001 donor-derived antigen-specific CD8+ T-cell treatment of relapsed AML after allogeneic hematopoietic cell transplantation (HCT)

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Allogeneic stem cell transplant outcomes between TBI-containing reduced intensity and myeloablative conditioning regimens for ALL in complete remission

Does Choice of Salvage Regimen Impact Stem Cell Mobilization in Hodgkin's Lymphoma?

Incidence, Risk Factors and Outcomes of Cardiac Toxicity in Haploidentical Peripheral Stem Cell Transplantation with High Dose Cyclophosphamide

Grade 3-4 cytokine release syndrome is associated with poor survival in haploidentical peripheral blood stem cell transplantation

Outcome of Severe Aplastic Anemia Post Allogenic Stem Cell Transplant with Mycophenolate and Calcineurin Inhibitor for Graft Versus Host Disease Prophylaxis

Incidence, Risk Factors and Outcomes of Pancytopenia Following Chimeric Antigen Receptor (CAR)-T Cell Therapy in Relapsed Refractory Diffuse Large B Cell Lymphoma

Suchergebnisse filtern